TNFAIP3 and allergic disease: Intranasally administration of IRL201104, a peptide derived from M. tuberculosis chaperonin 60.1, led to a significant increase in A20 expression in the lung of OVA-sensitized mice and a long-lasting anti-allergic effect, which at least partially explained the protective effects of tuberculosis against allergic diseases (45).